Yulan Sun

Ivonescimab Plus Chemotherapy in Non–Small Cell Lung Cancer With <i>EGFR</i> Variant

Wen‐Feng Fang, Yuanyuan Zhao, Yongzhong Luo et al. · JAMA · 2024 · 168 citations · Full text

Medicine, Oncology, Pharmacology +16

A NADPH Oxidase–Dependent Redox Signaling Pathway Mediates the Selective Radiosensitization Effect of Parthenolide in Prostate Cancer Cells

Yulan Sun, Daret K. St. Clair, Yong Xu et al. · Cancer Research · 2010 · 137 citations · Full text

Life Sciences, Cell Biology, Oncology +17

Ivonescimab versus pembrolizumab for PD-L1-positive non-small cell lung cancer (HARMONi-2): a randomised, double-blind, phase 3 study in China

Anwen Xiong, Lei Wang, Jianhua Chen et al. · The Lancet · 2025 · 133 citations

Medicine, Oncology, Pharmacology +13

The radiosensitization effect of parthenolide in prostate cancer cells is mediated by nuclear factor-κB inhibition and enhanced by the presence of PTEN

Yulan Sun, Daret K. St. Clair, Fang Fang et al. · Molecular Cancer Therapeutics · 2007 · 86 citations · Full text

Medicine, Oncology, Pharmacology +15

RelB Enhances Prostate Cancer Growth: Implications for the Role of the Nuclear Factor-κB Alternative Pathway in Tumorigenicity

Yong Xu, Sajni Josson, Fang Fang et al. · Cancer Research · 2009 · 72 citations · Full text

Medicine, Molecular Biology, Oncology +13